U.S. markets open in 2 hours 27 minutes

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.760.00 (0.00%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 6/13/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 37.10%
S&P500 52-Week Change 338.51%
52 Week High 319.43
52 Week Low 38.51
50-Day Moving Average 311.06
200-Day Moving Average 312.62

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 3774.55k
Shares Outstanding 5143.88M
Implied Shares Outstanding 6N/A
Float 119.18M
% Held by Insiders 117.34%
% Held by Institutions 156.11%
Shares Short (May 27, 2021) 414.48M
Short Ratio (May 27, 2021) 416.46
Short % of Float (May 27, 2021) 412.15%
Short % of Shares Outstanding (May 27, 2021) 410.06%
Shares Short (prior month Apr 29, 2021) 415.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -94.38%
Operating Margin (ttm)-99.95%

Management Effectiveness

Return on Assets (ttm)-11.23%
Return on Equity (ttm)-28.73%

Income Statement

Revenue (ttm)131.4M
Revenue Per Share (ttm)0.93
Quarterly Revenue Growth (yoy)101.00%
Gross Profit (ttm)-62.45M
EBITDA -125.09M
Net Income Avi to Common (ttm)-124.02M
Diluted EPS (ttm)-0.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)587.08M
Total Cash Per Share (mrq)4.08
Total Debt (mrq)42.34M
Total Debt/Equity (mrq)9.02
Current Ratio (mrq)4.57
Book Value Per Share (mrq)3.27

Cash Flow Statement

Operating Cash Flow (ttm)120.22M
Levered Free Cash Flow (ttm)3.86M